QPPV.COM KNOWLEDGE ASSESSMENT

Signal Prioritisation in Pharmacovigilance

Test your understanding of the concepts covered by Signal Prioritisation in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which signal is most likely to have significant benefit-risk implications?

A fully characterised, non-serious event with no effect on treatment decisions A potential risk that could alter prescribing, approved indications or the need for additional monitoring A data-entry discrepancy with no clinical interpretation A known event that has no effect on the product's risk management measures

Question 2 of 10 At which point in the simplified signal management process does prioritisation normally occur?

Before signal detection Between signal detection and validation After validation and before detailed assessment After regulatory action or closure

Question 3 of 10 Which feature most directly increases the novelty component of a prioritisation decision?

The event is already extensively characterised in the product information The signal represents an entirely new and previously unrecognised safety issue The event has been reviewed repeatedly without any change in understanding The signal is based on a stable background reporting pattern

Question 4 of 10 Which characteristic is most important when choosing between a formal scoring system and structured expert review?

The method must produce the highest possible numerical score The method should be applied consistently and supported by scientific justification The method should avoid documenting reviewer judgement The method should be identical for every organisation regardless of portfolio context

Question 5 of 10 Which evidence profile generally supports a higher priority, all other factors being comparable?

One poorly documented report without a plausible mechanism Reports from multiple independent sources with consistent findings and epidemiological support A single report that cannot be medically evaluated An isolated observation contradicted by all other available evidence

Question 6 of 10 Which situation best illustrates why limited evidence can still justify urgent prioritisation?

A single poor-quality report of a transient, non-serious symptom A single plausible report of a fatal or life-threatening event associated with widespread exposure A well-characterised event with stable reporting and no regulatory implications A minor laboratory abnormality with no evidence of increasing occurrence

Question 7 of 10 Which record would provide the strongest evidence that a priority assignment was reproducible during an inspection?

An undocumented verbal opinion from a reviewer A completed scoring record linked to the signal identifier, with rationale, reviewer identity and timestamp A general statement that the organisation uses a risk-based approach A list of all reports received without any prioritisation decision

Question 8 of 10 Which operational control most improves the auditability of a prioritisation process?

Allowing reviewers to retain scoring calculations in personal files Maintaining system-generated audit trails linking signal identifiers to scores, comments, reviewers and timestamps Recording only the final priority category without the underlying rationale Deleting superseded scores to avoid confusion

Question 9 of 10 Which consideration is most relevant when evaluating the public health impact of a signal?

Only the number of reports in the database Only the seriousness of the most severe individual case Exposure, vulnerable populations, preventability and availability of alternatives Whether the signal was detected by a spontaneous reporting system

Question 10 of 10 What is the most accurate description of the QPPV's typical role in signal prioritisation?

The QPPV personally assigns the priority classification to every validated signal The QPPV has no role until a regulatory authority requests information The QPPV provides governance oversight and should have visibility of highly prioritised signals and emerging safety issues The QPPV performs all clinical and epidemiological analyses supporting the score

Signal Prioritisation in Pharmacovigilance

Cookie Settings